EGFR and cancer: The precise mechanism may be associated with the role of RBM38 and GAS5 in EGFR activation, c-Jun activation, autophagy, protein kinase B activation, formation of a hypoxic environment, dysregulation of apoptosis, cancer stem cell renewal, and epithelial–mesenchymal transition.